Grattis, mottagare av CIMED medel 2023-2025 i ANA Futura
Goda nyheter! 11 forskare från ANA Futura har mottagit CIMED projektmedel 2023-2025.
CIM
CIMED projektmedel 2023-2025 Junior
Andreas Björklund
Projekttitel: Fas I/II prövning med adaptiva NK-celler mot högrisk myelodysplastiskt syndrom och akut myeloisk leukemi.
Angélica Cuapio Gómez
Projekttitel: Natural killer cells as fate determinants of the adaptive immune response following vaccination.
Chris Tibbitt
Projekttitel: Delineating the metabolic programs of tissue resident type 2 lymphocytes for identification of novel treatment targets and patient stratification in asthma.
Martin Ivarsson
Projekttitel: Uterine immune cell profiling of patients with early pregnancy bleeding.
Ping Chen
Projekttitel: Developing and employing data-driven strategies to decipher the roles of monocytes in non-alcoholic fatty liver disease progression.
CIMED projektmedel 2023-2025 Senior
Anna Norrby-Teglund
Projekttitel: Data-driven Precision Medicine in Sepsis.
Labmed
CIMED projektmedel 2023-2025 Junior
Anna Pasetto
Projekttitel: Design av neoantigen-baserat vacciner mot levercancer.
CIMED projektmedel 2023-2025 Senior
Mikael Björnstedt
Projekttitel: Molecular profiling of hepatopancreatobiliary cancer and its clinical correlation as a basis for novel treatment regimens.
Peter Bergman
Project title: Nytt ljus över Primär Immunbrist hos vuxna – tidig upptäckt, bättre diagnostik och ny behandling kan rädda liv
Stephan Mielke
Projekttitel: Detection and quantification of circulating CAR T cells and associated extracellular vesicles as novel tools for decision making in a real-world clinical environment.
CLINTEC
CIMED projektmedel 2023-2025 Junior
Arwen Stikvoort
Projekttitel: Development and in vitro/vivo efficacy of CD34/CD16 bispecific antibodies (BiKE) to treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS).